Creating the psilocybin services Act, and providing penalties

The inclusion of this explanation does not constitute agreement with the explanation’s substance by the members of the general assembly. This bill relates to psilocybin, including the creation of the psilocybin services Act, to, in part, provide for administration of psilocybin products to individuals years of age and older in the state. cubensis mushrooms. The bill provides definitions used in the bill and the purposes of the bill. The bill provides for a one-year program development period beginning January 1, 2022, and ending not later than December 31, 2022; requires the department of public health (DPH) to prescribe forms and adopt rules necessary for the administration of the Code chapter no later than January 1, 2023; and requires DPH to begin receiving applications for licensure of the various entities involved under the bill by February 1, 2023. The bill establishes the duties of DPH including licensing the entities required to be licensed to perform the various activities under the Code chapter; determination of the qualifications, education, training, and examination requirements of these entities; labeling and packaging requirements for psilocybin products; penalties; and enforcement. The bill also creates a psilocybin advisory board tasked with making recommendations to DPH and providing general oversight of the provisions of the bill. The bill includes application and licensing provisions for psilocybin product manufacturing facilities, psilocybin service centers, psilocybin service facilitators, and psilocybin testing laboratories; provisions for the permitting of licensee representatives; and provisions relating to the operation of the various entities. A licensee or licensee representative who sells or delivers a psilocybin product to a person under years of age is guilty of a simple misdemeanor. A simple misdemeanor is punishable by confinement for no more than days and a fine of at least $105 but not more than $855. The bill also provides for application of the Code chapter and a severability provision. The bill also exempts psilocybin from the application of Code chapter 124 (controlled substances) when manufactured, planted, cultivated, grown, harvested, produced, prepared, propagated, compounded, converted, processed, handled, transported, delivered, marketed, distributed, possessed, administered, consumed, tested, or otherwise used in accordance and compliance with the bill.